Details of Disease
General Information of Disease (ID: DISO8ZXF)
Disease Name | Congenital myasthenic syndrome 4A | |||||
---|---|---|---|---|---|---|
Synonyms |
congenital myasthenic syndrome type Ia1, formerly; myasthenic syndrome, congenital, 4A, slow-channel; congenital myasthenic syndrome type Ia1; Cms Ia1, formerly; Cms Ia1; congenital myasthenic syndrome type 4A; congenital myasthenic syndrometype Ia1; CMS Ia1; congenital myasthenic syndrome 4A slow-channel; CMS4A; CMS1A1
|
|||||
Definition |
A congenital myasthenic syndrome characterized by postsynaptic neuromuscular junction defects, early-onset progressive muscle weakness, and prolonged opening and activity of the acetylcholine receptor channel that has material basis in heterozygous or rarely biallelic mutation in the CHRNE gene on chromosome 17p13.
|
|||||
Disease Hierarchy | ||||||
Disease Identifiers | ||||||
Molecular Interaction Atlas (MIA) of This Disease
Molecular Interaction Atlas (MIA) | ||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
This Disease Is Related to 2 DOT Molecule(s)
|
||||||||||||||||||||||||||||||
References